Anixa Biosciences Inc Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Anixa Biosciences Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Anixa Biosciences Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending January 31, 2024 was $2.26M.
  • Anixa Biosciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $366K, a 19% decline from 2022.
  • Anixa Biosciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $452K, a 98.6% decline from 2021.
  • Anixa Biosciences Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $31.6M, a 236% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $366K -$86K -19% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-16
2022 $452K -$31.1M -98.6% Nov 1, 2021 Oct 31, 2022 10-K 2024-01-16
2021 $31.6M +$22.2M +236% Nov 1, 2020 Oct 31, 2021 10-K 2023-01-04
2020 $9.41M +$3.7M +65% Nov 1, 2019 Oct 31, 2020 10-K 2022-01-04
2019 $5.7M +$3.17M +126% Nov 1, 2018 Oct 31, 2019 10-K 2021-01-07
2018 $2.53M -$4.85M -65.8% Nov 1, 2017 Oct 31, 2018 10-K 2020-01-09
2017 $7.38M +$7.39M Nov 1, 2016 Oct 31, 2017 10-K 2019-01-11
2016 -$2.68K* +$398K Nov 1, 2015 Oct 31, 2016 10-K 2018-01-09
2015 -$401K -$7.75M -105% Nov 1, 2014 Oct 31, 2015 10-K/A 2016-12-08
2014 $7.35M +$4.1M +126% Nov 1, 2013 Oct 31, 2014 10-K 2015-12-23
2013 $3.25M +$2.29M +239% Nov 1, 2012 Oct 31, 2013 10-K 2015-01-29
2012 $958K -$1.58M -62.2% Nov 1, 2011 Oct 31, 2012 10-K/A 2014-01-17
2011 $2.53M +$1.29M +103% Nov 1, 2010 Oct 31, 2011 10-K 2013-01-29
2010 $1.25M Nov 1, 2009 Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.